Johns Hopkins MedicineCardiac Surgery Team Doubles Size in Two Years

Enhancing Cardiac Care: Johns Hopkins’ Strategic Expansion and its Impact on Heart Surgery

In an ambitious stride towards revolutionizing cardiac care, Johns Hopkins has significantly expanded its cardiac surgery team, underlining its commitment to providing unparalleled care. James Gammie, the cardiac surgeon-in-chief, highlights the program’s achievements and the strategic recruitment that has doubled the team’s size, bringing in world-renowned talent. This move not only reinforces Johns Hopkins’ position as a leading cardiac care provider but also promises advancements in treatment and research for complex heart conditions.

Key Points:

• Johns Hopkins is the busiest cardiac surgery program in Maryland, with a strong emphasis on delivering the highest quality of care.
• The surgical team at Johns Hopkins has doubled in size over the past two years, a testament to its targeted recruitment strategy.
• Duke Cameron, an internationally recognized heart surgeon, has rejoined Johns Hopkins, bringing his expertise in surgical repair of the aorta and connective tissue disorders.
• Reed Quinn joins Suburban Hospital, bringing decades of experience in both adult and pediatric cardiac surgery, further strengthening the team’s capabilities.
• Michael Robich has been appointed as the surgical director of structural heart disease, coming from Tufts Medical Center with a rich background in myocardial repair research.
• Antonio Polanco, specializing in advanced heart failure treatment and heart transplantation, has joined from Oschner Medical Center, highlighting the program’s focus on cutting-edge transplant techniques.
• Chetan Pasrija, a heart transplant surgeon with a prolific research background, has been welcomed from Vanderbilt University, indicating the program’s commitment to innovation in heart and lung preservation for transplant.
• Hanghang Wang, with a PhD in computational biology and bioinformatics, joins the team, aiming to advance research on biomarkers for type A dissection patients, a critical area in emergency diagnostics.

“We’re the busiest cardiac surgery program in Maryland. I’m so, so proud of the work we do here, and I want people to know they can expect the absolute best possible care at Johns Hopkins.”
– Dr. James Gammie, Cardiac Surgeon-in-Chief and Surgical Director of the Johns Hopkins Heart and Vascular Institute

More Medical University Press